Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2019) Scott M. Grundy et al.   CIRCULATION

Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease

(2019) Shuaib M. Abdullah et al.   CIRCULATION

Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses

(2019) Yi-Qian Sun et al.   BMJ-British Medical Journal

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users

(2019) Sung et al.   Journal of Clinical Medicine

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering

(2018) Eliano P. Navarese et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of change in total cholesterol level with mortality: A population-based study

(2018) Su-Min Jeong et al.   PLoS One

Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies

(2017) Christian M. Madsen et al.   EUROPEAN HEART JOURNAL

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization

(2017) James R. Staley et al.   GENETIC EPIDEMIOLOGY

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship

(2014) Stephen Burgess et al.   EPIDEMIOLOGY

Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: A population-based register study

(2013) Lise Bathum et al.   SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds

(2010) L. K. Petersen et al.   AGE AND AGEING

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders

(2008) J. L. Akerblom et al.   AGE AND AGEING